MON-607 Uptake of Novel Foot Mat Technology for Detection of Diabetic Foot Ulcers in High-Risk Patients Living with Diabetes

Abstract Disclosure: K. Yang: None. G. Rothenberg: Podimetrics. R. Lopez Fanas: None. L. Rincon Rueda: None. A.K. Myers: Eli Lilly & Company, ROM Technologies. D. Levy: None. J. Daily: None. Globally, a lower extremity limb is amputated every 30 seconds due to the increasing burden of diabetic foot ulcers (DFU). Prior studies have demonstrated that foot temperature monitoring is a preventive modality that can reduce the incidence of DFU and health resource utilization. To test the uptake of a foot monitoring mat (Podimetrics SmartMatTM, Somerville Mass) in an urban setting, we conducted a pilot study of 20 adult high-risk patients living with diabetes, peripheral neuropathy, a history of prior DFUs, and previous hospitalization(s) due to DFU-related complications. Participants were recruited from a referral podiatry clinic in the Bronx, NY with an exclusion criterion of prior above or below the knee amputation. All participants were mailed a Podimetrics mat and were trained to use the mat. Podimetrics team monitored daily usage to generate descriptive data on daily usage. The primary outcome was adherence to stepping on the monitoring mat (defined as stepping on the mat at least 4 times a week) over a six-month period. Majority of patients were male (85%) with an average age of 62 years, and Black (60%). They had an average HbA1c of 6.9%, 19/20 had peripheral neuropathy, 16/20 patients had a prior history of DFU-related amputations, and 13/20 had peripheral arterial disease. Our data showed both a high average adherence (using the mat 6.0 days per week) and a high overall adherence (range of 4.1-6.9 days of use per week). There was one participant lost to follow-up due to non-study related death. Our findings indicate the uptake of a foot temperature monitoring device can be highly adherable for patients living with diabetes and can be useful in high-risk patients to prevent DFU and enhance limb salvage in patients living with diabetes. Presentation: Monday, July 14, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.969
Primary Topic
Diabetic Foot Ulcer Assessment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MON-607 Uptake of Novel Foot Mat Technology for Detection of Diabetic Foot Ulcers in High-Risk Patients Living with Diabetes

Johanna P. Daily, Alyson K. Myers, Gary M. Rothenberg, Kwang Ik Yang et al.
Journal of the Endocrine Society
Diabetic Foot Ulcer Assessment and Management
article

MON-607 Uptake of Novel Foot Mat Technology for Detection of Diabetic Foot Ulcers in High-Risk Patients Living with Diabetes

Johanna P. Daily, Alyson K. Myers, Gary M. Rothenberg, Kwang Ik Yang, Daniel A Levy, Raul Lopez Fanas, Laura Rueda
article en

Abstract

Abstract Disclosure: K. Yang: None. G. Rothenberg: Podimetrics. R. Lopez Fanas: None. L. Rincon Rueda: None. A.K. Myers: Eli Lilly & Company, ROM Technologies. D. Levy: None. J. Daily: None. Globally, a lower extremity limb is amputated every 30 seconds due to the increasing burden of diabetic foot ulcers (DFU). Prior studies have demonstrated that foot temperature monitoring is a preventive modality that can reduce the incidence of DFU and health resource utilization. To test the uptake of a foot monitoring mat (Podimetrics SmartMatTM, Somerville Mass) in an urban setting, we conducted a pilot study of 20 adult high-risk patients living with diabetes, peripheral neuropathy, a history of prior DFUs, and previous hospitalization(s) due to DFU-related complications. Participants were recruited from a referral podiatry clinic in the Bronx, NY with an exclusion criterion of prior above or below the knee amputation. All participants were mailed a Podimetrics mat and were trained to use the mat. Podimetrics team monitored daily usage to generate descriptive data on daily usage. The primary outcome was adherence to stepping on the monitoring mat (defined as stepping on the mat at least 4 times a week) over a six-month period. Majority of patients were male (85%) with an average age of 62 years, and Black (60%). They had an average HbA1c of 6.9%, 19/20 had peripheral neuropathy, 16/20 patients had a prior history of DFU-related amputations, and 13/20 had peripheral arterial disease. Our data showed both a high average adherence (using the mat 6.0 days per week) and a high overall adherence (range of 4.1-6.9 days of use per week). There was one participant lost to follow-up due to non-study related death. Our findings indicate the uptake of a foot temperature monitoring device can be highly adherable for patients living with diabetes and can be useful in high-risk patients to prevent DFU and enhance limb salvage in patients living with diabetes. Presentation: Monday, July 14, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Albert Einstein College of Medicine (US), Montefiore Medical Center (US), University of Michigan (US), Sensimetrics Corporation (US)
Openalex Percentile: Top 59%
Diabetic Foot Ulcer Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.